FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1805787625> ?p ?o ?g. }

• W1805787625 abstract "Infection with HTLV-1 causes adult T-cell leukemia and tropical spastic paraparesis in different subsets of infected people. Treatments for HTLV-1-associated diseases are unspecific and unsatisfactory. Prophylactic measures have not been developed. Although HTLV-1 pathogenesis involves multiple stages and factors, high proviral load has been singled out as a major risk factor which predicts disease. HTLV-1 encodes Tax transactivator that potently activates transcription from viral long terminal repeats (LTR) and cellular promoters harbouring cAMP-responsive or KB element. Blocking Tax activity in infected cells should provide prophylactic and therapeutic benefits. In this study, we characterize the negative regulatory role of SIRT1 deacetylase in Tax-induced activation of HTLV-1 LTR. SIRT1 is a sirtuin with anti-cancer and anti-aging activity. Whereas over expression of SIRT1 abolished the activity of Tax to activate the LTR, compromising SIRT1 by RNA interference augmented Tax activation of the LTR. Resveratrol is a natural inhibitor of SIRT1 widely sold as a nutritional supplement and extensively tested for beneficial effects in various diseases. A SIRT1-dependent inhibition of the transcriptional activity of Tax was observed in cells treated with resveratrol. Consistently, treatment of HTLV-1-transformed T cells with resveratrol led to the activation of SIRT1 and the suppression of HTLV-1 proviral transcription. On the contrary, specific inhibition of SIRT1 by Sirtinol or Ex527 promoted HTLV-1 mRNA expression. The amount of HTLV-1 virion collected from culture supernatant was decreased in MT2 cells treated with resveratrol. Tax was found to interact with SIRT1 in HTLV-1-transformed T cells. Administration of resveratrol blocked the interaction of Tax with CREB and suppressed the recruitment of CREB and CRTC1 to the LTR. Taken together, our findings document the suppression of Tax activation of HTLV-1 transcription by SIRT1 and reveal potential benefits of small-molecule activators of SIRT1 such as resveratrol in the prevention and intervention of HTLV-1-associated diseases. Supported by SKY-MRF (2011), HK-RGC (HKU7674/12M, HKU7686/13M and HKU1/CRF/11G) and HK-HMRF (13121052) grants." @default.
• W1805787625 created "2016-06-24" @default.
• W1805787625 creator A5024217010 @default.
• W1805787625 creator A5038876168 @default.
• W1805787625 creator A5044150113 @default.
• W1805787625 creator A5048329643 @default.
• W1805787625 creator A5068365109 @default.
• W1805787625 creator A5085550555 @default.
• W1805787625 date "2015-08-28" @default.
• W1805787625 modified "2023-10-16" @default.
• W1805787625 title "Suppression of HTLV-1 transcription by SIRT1 deacetylase" @default.
• W1805787625 doi "https://doi.org/10.1186/1742-4690-12-s1-p53" @default.
• W1805787625 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4578124" @default.
• W1805787625 hasPublicationYear "2015" @default.
• W1805787625 type Work @default.
• W1805787625 sameAs 1805787625 @default.
• W1805787625 citedByCount "0" @default.
• W1805787625 crossrefType "journal-article" @default.
• W1805787625 hasAuthorship W1805787625A5024217010 @default.
• W1805787625 hasAuthorship W1805787625A5038876168 @default.
• W1805787625 hasAuthorship W1805787625A5044150113 @default.
• W1805787625 hasAuthorship W1805787625A5048329643 @default.
• W1805787625 hasAuthorship W1805787625A5068365109 @default.
• W1805787625 hasAuthorship W1805787625A5085550555 @default.
• W1805787625 hasBestOaLocation W18057876251 @default.
• W1805787625 hasConcept C138885662 @default.
• W1805787625 hasConcept C159047783 @default.
• W1805787625 hasConcept C179926584 @default.
• W1805787625 hasConcept C41895202 @default.
• W1805787625 hasConcept C502942594 @default.
• W1805787625 hasConcept C60644358 @default.
• W1805787625 hasConcept C70721500 @default.
• W1805787625 hasConcept C71924100 @default.
• W1805787625 hasConcept C86803240 @default.
• W1805787625 hasConceptScore W1805787625C138885662 @default.
• W1805787625 hasConceptScore W1805787625C159047783 @default.
• W1805787625 hasConceptScore W1805787625C179926584 @default.
• W1805787625 hasConceptScore W1805787625C41895202 @default.
• W1805787625 hasConceptScore W1805787625C502942594 @default.
• W1805787625 hasConceptScore W1805787625C60644358 @default.
• W1805787625 hasConceptScore W1805787625C70721500 @default.
• W1805787625 hasConceptScore W1805787625C71924100 @default.
• W1805787625 hasConceptScore W1805787625C86803240 @default.
• W1805787625 hasIssue "S1" @default.
• W1805787625 hasLocation W18057876251 @default.
• W1805787625 hasLocation W18057876252 @default.
• W1805787625 hasLocation W18057876253 @default.
• W1805787625 hasOpenAccess W1805787625 @default.
• W1805787625 hasPrimaryLocation W18057876251 @default.
• W1805787625 hasRelatedWork W1973440249 @default.
• W1805787625 hasRelatedWork W2056646110 @default.
• W1805787625 hasRelatedWork W2066415979 @default.
• W1805787625 hasRelatedWork W2080339774 @default.
• W1805787625 hasRelatedWork W2147751799 @default.
• W1805787625 hasRelatedWork W2168083515 @default.
• W1805787625 hasRelatedWork W3119732228 @default.
• W1805787625 hasRelatedWork W4366782474 @default.
• W1805787625 hasRelatedWork W2426114511 @default.
• W1805787625 hasRelatedWork W2897837901 @default.
• W1805787625 hasVolume "12" @default.
• W1805787625 isParatext "false" @default.
• W1805787625 isRetracted "false" @default.
• W1805787625 magId "1805787625" @default.
• W1805787625 workType "article" @default.